GL1X · GenesisL1 explorer

Research workbench

Cystal structure of HIV-1 active site mutant D25N and P2-nc analog inhibitor

Analyse Cystal structure of HIV-1 active site mutant D25N and P2-nc analog inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3BVA
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease (retropepsin)
EC
3.4.23.16
UniProt
P03367
Ligands
2NC
Pockets
1 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 55% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProtease (retropepsin) (EC 3.4.23.16)protein994% helix, 55% strandP03367

Ligands and binding sites

  • 2NC · N-{(2S)-2-[(N-acetyl-L-threonyl-L-isoleucyl)amino]hexyl}-L-norleucyl-L-glutaminyl-N~5~-[amino(iminio)methyl]-L-ornithinamide · ligand · chains A, B
  • GOL · Glycerol · additive · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13830.720.83442NC

Interfaces

1 interface between chains.

  • A–B · 1848 Ų buried · 36 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent (additive adduct).

Compared structures

  • 3BVA · Cystal structure of HIV-1 Active Site Mutant D25N and p2-NC analog inhibitor · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.